— Know what they know.
Not Investment Advice
Also trades as: 0HI3.L (LSE) · $vol 0M

ARWR NASDAQ

Arrowhead Pharmaceuticals, Inc.
1W: -5.3% 1M: +2.1% 3M: +18.7% YTD: +11.4% 1Y: +363.5% 3Y: +100.6% 5Y: +3.7%
$74.95
-0.59 (-0.78%)
 
Weekly Expected Move ±7.6%
$65 $71 $77 $83 $88
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 54 · $10.6B mcap · 123M float · 1.71% daily turnover · Short 75% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
45.4 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 201.4%
Cost Advantage ★
54
Intangibles
51
Switching Cost
40
Network Effect
52
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ARWR shows a Weak competitive edge (45.4/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 201.4% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$46
Low
$68
Avg Target
$90
High
Based on 2 analysts since May 7, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 15Hold: 5Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$78.67
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-13 Bernstein $35 $46 +11 -41.8% $79.04
2026-05-08 Chardan Capital $80 $90 +10 +15.5% $77.95
2026-04-21 Morgan Stanley $78 $100 +22 +44.4% $69.25
2026-02-06 Morgan Stanley $81 $78 -3 +17.1% $66.64
2026-01-27 Robert W. Baird Initiated $81 +20.9% $67.02
2026-01-21 H.C. Wainwright $85 $100 +15 +45.3% $68.80
2026-01-13 UBS Initiated $110 +61.7% $68.03
2026-01-13 Piper Sandler $100 $110 +10 +66.8% $65.93
2026-01-07 Morgan Stanley $48 $81 +33 +14.4% $70.81
2026-01-07 Chardan Capital Initiated $80 +13.0% $70.81
2026-01-02 Tudor Pickering William Pickering Initiated $35 -47.3% $66.39
2025-12-31 Bernstein $24 $35 +11 -48.0% $67.25
2025-12-17 Piper Sandler Edward Tenthoff $52 $100 +48 +54.7% $64.66
2025-12-11 RBC Capital $50 $80 +30 +16.1% $68.91
2025-12-02 H.C. Wainwright $60 $85 +25 +51.1% $56.25
2025-11-26 Morgan Stanley $37 $48 +11 +2.6% $46.79
2024-11-29 Bernstein William Pickering Initiated $24 -7.0% $25.81
2024-11-27 Loop Capital Markets Keay Nakae Initiated $60 +365.1% $12.90
2024-09-03 Citigroup David Lebowitz Initiated $27 +17.9% $22.91
2024-07-05 H.C. Wainwright Patrick Trucchio $90 $60 -30 +369.9% $12.77
2024-06-04 Goldman Sachs Andrea Tan $85 $31 -54 +22.6% $25.29
2024-05-30 RBC Capital Luca Issi $77 $50 -27 +337.4% $11.43
2023-02-07 RBC Capital Initiated $77 +368.1% $16.45
2023-02-07 Piper Sandler Initiated $52 +55.2% $33.51
2022-12-06 H.C. Wainwright Initiated $90 +471.4% $15.75
2022-11-29 Jefferies Initiated $75 +400.3% $14.99
2022-11-29 Morgan Stanley Initiated $37 +32.1% $28.00
2022-11-28 Leerink Partners Initiated $31 +10.7% $28.00
2022-01-18 Goldman Sachs Madhu Kumar Initiated $85 +58.0% $53.79

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ARWR receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-08 B- D+
2026-02-06 D+ B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

31 Grade D
Profitability
20
Balance Sheet
59
Earnings Quality
41
Growth
40
Value
27
Momentum
41
Safety
100
Cash Flow
20
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ARWR scores highest in Safety (100/100) and lowest in Profitability (20/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
5.15
Safe Zone
Piotroski F-Score
2/9
Beneish M-Score
-5.98
Unlikely Manipulator
Ohlson O-Score
-5.75
Bankruptcy prob: 0.3%
Low Risk
Credit Rating
BBB+
Score: 61.0/100
Trend: Improving
Earnings Quality
OCF/NI: 0.12x
Accruals: -21.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ARWR scores 5.15, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ARWR scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ARWR's score of -5.98 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ARWR's implied 0.3% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ARWR receives an estimated rating of BBB+ (score: 61.0/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-35.47x
PEG
0.00x
P/S
16.97x
P/B
17.39x
P/FCF
-175.53x
P/OCF
EV/EBITDA
-62.29x
EV/Revenue
13.47x
EV/EBIT
-52.41x
EV/FCF
-164.66x
Earnings Yield
-3.37%
FCF Yield
-0.57%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. ARWR currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.209
NI / EBT
×
Interest Burden
1.557
EBT / EBIT
×
EBIT Margin
-0.257
EBIT / Rev
×
Asset Turnover
0.493
Rev / Assets
×
Equity Multiplier
3.876
Assets / Equity
=
ROE
-92.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ARWR's ROE of -92.4% is driven by financial leverage (equity multiplier: 3.88x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 1.21 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$74.95
Median 1Y
$73.60
5th Pctile
$24.00
95th Pctile
$227.97
Ann. Volatility
66.3%
Analyst Target
$78.67
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Christopher Anzalone
President and Chief Executive Officer
$981,046 $6,810,292 $9,029,861
Patrick O’Brien Operating
rating Officer
$653,940 $1,979,000 $3,030,195
James Hamilton Medical
edical Officer
$617,512 $1,979,000 $2,966,213
Kenneth Myszkowski Financial
ief Financial Officer
$496,783 $1,979,000 $2,660,161
Daniel Apel Financial
ancial Officer
$232,212 $1,287,000 $1,754,912
Tracie Oliver Commercial
ef Commercial Officer
$43,193 $— $43,193

CEO Pay Ratio

52:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $9,029,861
Avg Employee Cost (SGA/emp): $174,322
Employees: 711

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
711
+16.8% YoY
Revenue / Employee
$1,166,594
Rev: $829,448,000
Profit / Employee
$-2,294
NI: $-1,631,000
SGA / Employee
$174,322
Avg labor cost proxy
R&D / Employee
$853,951
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -35.6% -32.4% -42.0% -25.7% -35.4% -43.6% -38.3% -37.2% -44.9% -61.3% -88.6% -1.4% -1.6% -2.6% -2.8% -63.0% -65.0% -0.5% 62.1% -92.4% -92.38%
ROA -28.9% -22.9% -29.7% -18.1% -25.0% -25.1% -22.0% -21.4% -25.8% -28.2% -40.7% -64.6% -73.9% -62.9% -67.1% -15.1% -15.6% -0.1% 16.0% -23.8% -23.83%
ROIC -63.4% -1.8% -2.2% -1.4% -1.9% -1.4% -1.2% -1.1% -1.4% -64.5% -94.2% -1.5% -1.7% -1.3% -1.4% -26.3% -23.9% -61.9% -3.1% 2.0% 2.01%
ROCE -27.9% -26.4% -33.4% -20.5% -27.7% -31.6% -27.2% -25.7% -30.4% -28.5% -42.8% -68.9% -79.6% -56.0% -57.9% -8.6% -7.2% 11.8% 29.0% -13.4% -13.43%
Gross Margin 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 76.0% 1.0% 42.5% 1.0% 1.0% 77.6% 1.0% 1.0% 1.0% 1.00%
Operating Margin -69.4% -1.7% -2.3% 27.4% -2.2% -2.7% -67.4% 32.9% -6.5% -6.7% -38.5% -6.9% -64.6% 70.2% -6.0% 17.2% 15.5% -1.9% -1.92%
Net Margin -65.2% -1.7% -2.3% 29.2% -2.2% -2.7% -66.1% 33.3% -6.5% -6.8% -37.4% -7.2% -69.2% 68.3% -6.3% -9.3% 11.7% -1.8% -1.80%
EBITDA Margin -65.1% -1.6% -2.2% 30.9% -2.1% -2.6% -58.0% 37.9% -6.0% -6.2% -36.3% -6.5% -59.3% 73.2% -5.3% 25.0% 21.7% -1.5% -1.46%
FCF Margin 1.6% 1.1% 85.7% -28.5% -48.0% -77.7% -84.9% -1.3% -1.3% -1.4% -2.2% -13.3% -27.1% -22.3% -21.9% 1.7% -3.0% 18.9% 29.5% -8.2% -8.18%
OCF Margin 1.7% 1.2% 1.0% -19.9% -36.6% -56.0% -54.0% -89.7% -77.0% -63.9% -1.1% -7.2% -17.9% -17.1% -18.8% 10.8% 3.7% 21.6% 31.1% -5.8% -5.84%
ROE 3Y Avg snapshot only -1.05%
ROE 5Y Avg snapshot only -76.15%
ROA 3Y Avg snapshot only -31.95%
ROIC Economic snapshot only -21.38%
Cash ROA snapshot only -2.62%
NOPAT Margin snapshot only -28.18%
Pretax Margin snapshot only -40.01%
R&D / Revenue snapshot only 1.11%
SGA / Revenue snapshot only 24.90%
SBC / Revenue snapshot only 8.28%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -68.48 -46.33 -37.87 -44.40 -24.19 -19.85 -27.83 -18.29 -21.07 -14.05 -11.07 -7.49 -5.99 -3.94 -3.67 -11.90 -14.80 -2869.63 46.18 -29.67 -35.473
P/S Ratio 80.10 47.19 47.99 18.84 14.90 14.37 15.45 10.07 14.89 11.98 18.09 99.40 164.29 87.07 89.97 3.01 3.68 5.64 8.56 14.36 16.973
P/B Ratio 18.67 15.96 16.95 12.14 9.11 8.77 10.79 6.89 9.57 10.63 12.11 12.99 11.90 12.74 12.66 9.24 11.85 10.04 20.04 19.16 17.385
P/FCF 51.55 44.20 56.02 -66.18 -31.07 -18.50 -18.21 -7.78 -11.13 -8.72 -8.16 -7.50 -6.07 -3.91 -4.11 178.55 -124.67 29.83 29.01 -175.53 -175.530
P/OCF 46.73 38.11 46.58 28.02 100.56 26.07 27.53
EV/EBITDA -65.70 -43.93 -36.74 -43.58 -23.22 -19.47 -28.63 -18.65 -22.43 -16.30 -12.17 -7.98 -6.31 -4.51 -4.34 -27.66 -45.10 25.04 23.74 -62.29 -62.293
EV/Revenue 77.36 44.72 45.62 17.54 13.53 13.16 14.39 8.99 13.74 11.89 17.97 98.83 163.26 93.37 96.52 3.31 3.97 4.98 8.06 13.47 13.467
EV/EBIT -62.02 -41.49 -34.99 -39.94 -21.69 -18.31 -26.63 -17.26 -20.92 -15.22 -11.56 -7.70 -6.10 -4.37 -4.20 -21.11 -31.54 29.29 25.46 -52.41 -52.407
EV/FCF 49.79 41.88 53.25 -61.62 -28.21 -16.94 -16.96 -6.94 -10.27 -8.66 -8.11 -7.46 -6.03 -4.19 -4.41 196.36 -134.37 26.31 27.29 -164.66 -164.658
Earnings Yield -1.5% -2.2% -2.6% -2.3% -4.1% -5.0% -3.6% -5.5% -4.7% -7.1% -9.0% -13.4% -16.7% -25.4% -27.3% -8.4% -6.8% -0.0% 2.2% -3.4% -3.37%
FCF Yield 1.9% 2.3% 1.8% -1.5% -3.2% -5.4% -5.5% -12.9% -9.0% -11.5% -12.3% -13.3% -16.5% -25.6% -24.4% 0.6% -0.8% 3.4% 3.4% -0.6% -0.57%
PEG Ratio snapshot only 0.003
Price/Tangible Book snapshot only 19.446
EV/Gross Profit snapshot only 13.603
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 7.92 2.62 2.62 2.62 2.62 2.92 2.92 2.92 2.92 3.98 3.98 3.98 3.98 6.74 6.74 6.74 6.74 4.86 4.86 4.86 4.863
Quick Ratio 7.82 2.59 2.59 2.59 2.59 3.07 3.07 3.07 3.07 3.98 3.98 3.98 3.98 6.74 6.74 6.74 6.74 4.86 4.86 4.86 4.863
Debt/Equity 0.05 0.06 0.06 0.06 0.06 0.20 0.20 0.20 0.20 1.41 1.41 1.41 1.41 4.59 4.59 4.59 4.59 0.79 0.79 0.79 0.786
Net Debt/Equity -0.64 -0.84 -0.84 -0.84 -0.84 -0.74 -0.74 -0.74 -0.74 -0.07 -0.07 -0.07 -0.07 0.92 0.92 0.92 0.92 -1.19 -1.19 -1.19 -1.187
Debt/Assets 0.04 0.04 0.04 0.04 0.04 0.12 0.12 0.12 0.12 0.50 0.50 0.50 0.50 0.75 0.75 0.75 0.75 0.26 0.26 0.26 0.264
Debt/EBITDA -0.17 -0.18 -0.14 -0.24 -0.18 -0.50 -0.58 -0.62 -0.52 -2.18 -1.43 -0.87 -0.75 -1.52 -1.47 -12.51 -16.23 2.22 0.99 -2.72 -2.724
Net Debt/EBITDA 2.32 2.43 1.91 3.23 2.35 1.79 2.11 2.24 1.88 0.11 0.07 0.05 0.04 -0.30 -0.29 -2.51 -3.26 -3.36 -1.49 4.11 4.113
Interest Coverage -52.81 -17.97 -12.88 -10.27 -13.56 -19.76 -22.89 -17.93 -12.34 -1.42 -0.91 1.58 3.83 -1.73 -1.729
Equity Multiplier 1.13 1.74 1.74 1.74 1.74 1.74 1.74 1.74 1.74 2.82 2.82 2.82 2.82 6.15 6.15 6.15 6.15 2.97 2.97 2.97 2.972
Cash Ratio snapshot only 4.703
Debt Service Coverage snapshot only -1.455
Cash to Debt snapshot only 2.510
FCF to Debt snapshot only -0.139
Defensive Interval snapshot only 403.6 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.25 0.22 0.23 0.43 0.41 0.35 0.40 0.39 0.37 0.33 0.25 0.05 0.03 0.03 0.03 0.60 0.63 0.66 0.86 0.49 0.493
Inventory Turnover 28.44 32.11 33.54 61.17 58.04
Receivables Turnover 142.85 24.92 26.02 47.46 45.03 41.70 47.72 46.77 43.93 341.47 257.79 50.32 27.87 243.10 319.75 182.30 182.300
Payables Turnover 14.87 16.98 17.74 32.35 30.69 39.47 45.17 44.27 41.58 11.80 8.57 1.25 0.68 0.97 0.97 0.78 0.84 0.43 0.43 0.43 0.428
DSO 3 15 14 8 8 9 8 8 8 1 1 7 13 0 0 0 0 2 1 2 2.0 days
DIO 13 11 11 6 6 -13 -11 -12 -12 -17 -24 -163 -300 0 0 0 0 0 0 0 0.0 days
DPO 25 21 21 11 12 9 8 8 9 31 43 292 537 377 377 470 436 852 852 852 852.3 days
Cash Conversion Cycle -9 5 4 2 3 -13 -12 -12 -13 -47 -65 -448 -823 -377 -377 -470 -436 -851 -851 -850 -850.3 days
Fixed Asset Turnover snapshot only 1.459
Cash Velocity snapshot only 0.677
Capital Intensity snapshot only 2.227
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue -13.0% 57.2% 80.9% 2.0% 1.3% 75.9% 92.7% 3.6% 2.5% -1.0% -34.7% -87.0% -92.3% -88.7% -85.6% 15.0% 29.4% 29.6% 40.8% 9.4% 9.35%
Net Income -4.2% -66.6% -78.3% -2.0% -22.3% -25.0% 15.6% -34.3% -17.7% -16.6% -92.1% -2.1% -2.0% -1.9% -1.2% 69.4% 72.4% 99.7% 1.3% -1.1% -1.09%
EPS -4.0% -63.7% -75.3% 1.8% -20.3% -23.6% 16.8% -34.1% -16.3% -14.9% -89.6% -1.7% -1.6% -1.6% -85.4% 72.0% 75.4% 99.8% 1.3% -97.4% -97.37%
FCF 2.9% 2.4% 2.0% -1.5% -1.7% -2.3% -2.9% -3.7% -1.9% -75.0% -70.5% -33.1% -55.2% -82.8% -41.9% 1.0% 96.7% 1.3% 1.6% -6.3% -6.30%
EBITDA -3.5% -61.4% -69.4% 4.7% -14.9% -16.8% 22.0% -24.0% -7.8% -6.8% -91.9% -2.3% -2.2% -2.2% -1.2% 84.5% 89.7% 1.3% 1.6% -97.4% -97.39%
Op. Income -3.0% -60.0% -67.6% -0.1% -18.8% -19.8% 16.5% -27.2% -13.1% -14.8% -90.3% -2.1% -2.0% -1.9% -1.1% 75.0% 80.3% 1.2% 1.5% -87.2% -87.17%
OCF Growth snapshot only -1.59%
Asset Growth snapshot only 21.54%
Equity Growth snapshot only 1.51%
Debt Growth snapshot only -57.00%
Shares Change snapshot only 5.90%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 99.3% 1.0% 45.1% 40.6% 22.3% 12.9% 19.4% 25.2% 27.5% 39.9% 31.5% -26.4% -43.3% -41.9% -43.5% 29.3% 33.6% 50.5% 57.7% 31.6% 31.62%
Revenue 5Y 2.6% 2.9% 1.0% 81.4% 61.5% 50.6% 55.6% 65.1% 79.9% 71.7% 30.9% -17.8% -32.2% -30.6% -30.7% 32.6% 37.0% 56.6% 68.7% 47.5% 47.49%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y -2.6%
FCF 5Y
OCF 3Y 3.1%
OCF 5Y
Assets 3Y 71.3% 85.3% 85.3% 85.3% 85.3% 25.5% 25.5% 25.5% 25.5% 13.6% 13.6% 13.6% 13.6% 17.1% 17.1% 17.1% 17.1% 26.0% 26.0% 26.0% 26.04%
Assets 5Y 31.6% 40.8% 40.8% 40.8% 40.8% 46.1% 46.1% 46.1% 46.1% 47.0% 47.0% 47.0% 47.0% 26.6% 26.6% 26.6% 26.6% 21.5% 21.5% 21.5% 21.53%
Equity 3Y 78.3% 62.2% 62.2% 62.2% 62.2% 17.7% 17.7% 17.7% 17.7% -16.2% -16.2% -16.2% -16.2% -23.2% -23.2% -23.2% -23.2% 5.4% 5.4% 5.4% 5.36%
Book Value 3Y 68.4% 57.4% 57.4% 57.1% 58.6% 14.4% 14.3% 15.3% 15.7% -17.4% -17.5% -20.9% -21.0% -27.0% -27.6% -28.6% -29.9% -3.0% -4.1% -3.9% -3.88%
Dividend 3Y
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.65 0.57 0.60 0.72 0.72 0.64 0.66 0.82 0.89 0.94 0.66 0.02 0.01 0.07 0.12 0.24 0.25 0.36 0.36 0.59 0.590
Earnings Stability 0.00 0.06 0.20 0.20 0.38 0.48 0.54 0.64 0.68 0.69 0.79 0.76 0.81 0.80 0.84 0.39 0.33 0.06 0.00 0.26 0.260
Margin Stability 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.91 0.90 0.94 0.86 0.93 0.93 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.20 0.50 0.500
Earnings Smoothness
ROE Trend -0.46 -0.39 -0.45 -0.17 -0.19 -0.18 -0.05 -0.12 -0.13 -0.36 -0.68 -1.41 -1.57 -2.63 -2.71 0.28 0.42 1.99 2.71 0.61 0.610
Gross Margin Trend 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.09 0.32 0.33 0.13 0.08 0.81 0.80 0.89 0.89 0.35 0.347
FCF Margin Trend 1.36 1.20 1.73 -1.05 -0.90 -0.70 -0.51 -2.08 -1.88 -1.52 -2.22 -12.46 -26.17 -21.19 -20.38 7.29 14.18 12.01 12.36 6.54 6.537
Sustainable Growth Rate 62.1%
Internal Growth Rate 19.1%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income -1.47 -1.22 -0.81 0.47 0.59 0.77 0.97 1.63 1.09 0.75 0.66 0.55 0.65 0.77 0.77 -0.42 -0.15 -110.09 1.68 0.12 0.121
FCF/OCF 0.91 0.86 0.83 1.43 1.31 1.39 1.57 1.44 1.74 2.15 2.05 1.83 1.52 1.31 1.16 0.16 -0.81 0.87 0.95 1.40 1.401
FCF/Net Income snapshot only 0.169
CapEx/Revenue 16.0% 17.0% 17.4% 8.6% 11.3% 21.7% 30.9% 39.8% 56.8% 73.4% 1.1% 6.0% 9.2% 5.2% 3.1% 9.1% 6.6% 2.7% 1.6% 2.3% 2.34%
CapEx/Depreciation snapshot only 0.574
Accruals Ratio -0.71 -0.51 -0.54 -0.10 -0.10 -0.06 -0.01 0.13 0.02 -0.07 -0.14 -0.29 -0.26 -0.14 -0.16 -0.22 -0.18 -0.14 -0.11 -0.21 -0.210
Sloan Accruals snapshot only 0.109
Cash Flow Adequacy snapshot only -2.493
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Total Payout Ratio 0.0%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -3.0% -0.3% -0.3% -0.4% -0.4% -0.3% -0.2% -0.2% -0.2% -0.1% -0.1% -12.3% -13.4% -18.3% -19.5% -15.8% -12.3% -5.8% -3.2% -3.1% -3.07%
Total Shareholder Return -3.0% -0.3% -0.3% -0.4% -0.4% -0.3% -0.2% -0.2% -0.2% -0.1% -0.1% -12.3% -13.4% -18.3% -19.5% -15.8% -12.3% -5.8% -3.2% -3.1% -3.07%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.02 1.02 1.01 1.01 0.99 0.98 0.98 0.98 0.98 0.99 0.95 0.96 -0.03 0.78 1.21 1.209
Interest Burden (EBT/EBIT) 0.94 0.95 0.97 0.97 0.99 0.99 1.01 1.04 1.07 1.10 1.07 1.05 1.04 1.06 1.08 1.71 2.05 0.39 0.75 1.56 1.557
EBIT Margin -1.25 -1.08 -1.30 -0.44 -0.62 -0.72 -0.54 -0.52 -0.66 -0.78 -1.55 -12.83 -26.76 -21.37 -23.01 -0.16 -0.13 0.17 0.32 -0.26 -0.257
Asset Turnover 0.25 0.22 0.23 0.43 0.41 0.35 0.40 0.39 0.37 0.33 0.25 0.05 0.03 0.03 0.03 0.60 0.63 0.66 0.86 0.49 0.493
Equity Multiplier 1.23 1.42 1.42 1.42 1.42 1.74 1.74 1.74 1.74 2.18 2.18 2.18 2.18 4.17 4.17 4.17 4.17 3.88 3.88 3.88 3.876
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-1.21 $-1.35 $-1.75 $-1.04 $-1.46 $-1.66 $-1.46 $-1.39 $-1.69 $-1.91 $-2.76 $-3.82 $-4.34 $-4.91 $-5.12 $-1.07 $-1.07 $-0.01 $1.44 $-2.11 $-2.11
Book Value/Share $4.44 $3.91 $3.91 $3.79 $3.87 $3.77 $3.76 $3.69 $3.72 $2.53 $2.53 $2.20 $2.18 $1.52 $1.49 $1.38 $1.33 $3.43 $3.31 $3.27 $4.21
Tangible Book/Share $4.29 $3.78 $3.78 $3.66 $3.74 $3.66 $3.65 $3.57 $3.61 $2.43 $2.43 $2.12 $2.10 $1.45 $1.42 $1.32 $1.27 $3.38 $3.26 $3.22 $3.22
Revenue/Share $1.03 $1.32 $1.38 $2.44 $2.36 $2.30 $2.62 $2.52 $2.39 $2.24 $1.69 $0.29 $0.16 $0.22 $0.21 $4.23 $4.29 $6.11 $7.75 $4.37 $4.37
FCF/Share $1.61 $1.41 $1.18 $-0.69 $-1.13 $-1.79 $-2.23 $-3.27 $-3.20 $-3.08 $-3.75 $-3.81 $-4.28 $-4.95 $-4.58 $0.07 $-0.13 $1.16 $2.29 $-0.36 $-0.36
OCF/Share $1.77 $1.64 $1.42 $-0.48 $-0.87 $-1.29 $-1.42 $-2.26 $-1.84 $-1.43 $-1.83 $-2.08 $-2.83 $-3.79 $-3.94 $0.45 $0.16 $1.32 $2.41 $-0.25 $-0.25
Cash/Share $3.03 $3.52 $3.52 $3.41 $3.48 $3.56 $3.55 $3.48 $3.52 $3.76 $3.76 $3.27 $3.25 $5.58 $5.45 $5.06 $4.90 $6.77 $6.53 $6.46 $12.53
EBITDA/Share $-1.22 $-1.35 $-1.72 $-0.98 $-1.38 $-1.55 $-1.32 $-1.22 $-1.47 $-1.64 $-2.50 $-3.56 $-4.09 $-4.60 $-4.65 $-0.51 $-0.38 $1.21 $2.63 $-0.94 $-0.94
Debt/Share $0.20 $0.24 $0.24 $0.24 $0.24 $0.77 $0.77 $0.75 $0.76 $3.57 $3.57 $3.11 $3.09 $6.98 $6.82 $6.33 $6.13 $2.70 $2.60 $2.57 $2.57
Net Debt/Share $-2.83 $-3.27 $-3.27 $-3.17 $-3.24 $-2.79 $-2.78 $-2.73 $-2.76 $-0.19 $-0.19 $-0.16 $-0.16 $1.40 $1.37 $1.27 $1.23 $-4.08 $-3.93 $-3.88 $-3.88
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score 5.153
Altman Z-Prime snapshot only 9.603
Piotroski F-Score 4 4 4 4 3 3 4 2 2 4 4 3 3 3 3 6 6 6 6 2 2
Beneish M-Score -4.50 0.62 3.31 2.14 11.63 -3.90 -2.35 -2.83 -3.79 -5.11 -8.97 -2.12 -3.42 5.42 90.41 -5.98 -5.980
Ohlson O-Score snapshot only -5.753
ROIC (Greenblatt) snapshot only -13.53%
Net-Net WC snapshot only $0.48
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB+
Credit Score 81.85 81.44 82.23 74.36 75.05 74.33 63.72 63.28 63.48 39.31 39.59 34.70 34.58 23.71 23.84 25.03 28.96 70.03 84.28 60.98 60.983
Credit Grade snapshot only 8
Credit Trend snapshot only 35.958
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 55
Sector Credit Rank snapshot only 53

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms